🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
25.89
-0.28 (-1.07%)
Nov 20, 2026, 12:34 PM EST - Market open

IDEAYA Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
36.54218.71723.3950.9327.94
Revenue Growth
-82.99%3024.43%-70.07%-54.09%82.28%43.01%
Cost of Revenue
412.59314.7294.67129.5189.5458.16
Gross Profit
-376.05-95.99-287.67-106.12-38.61-30.22
Selling, General & Admin
86.9863.3239.328.3123.920.05
Operating Expenses
86.9863.3239.328.3123.920.05
Operating Income
-463.04-159.31-326.98-134.43-62.5-50.27
Interest & Investment Income
33.0535.6429.279.923.152.34
EBT Excluding Unusual Items
-429.99-123.67-297.71-124.51-59.35-47.93
Gain (Loss) on Sale of Investments
9.989.9823.2311.550.7-1.83
Pretax Income
-420.01-113.7-274.48-112.96-58.66-49.76
Net Income
-420.01-113.7-274.48-112.96-58.66-49.76
Net Income to Common
-420.01-113.7-274.48-112.96-58.66-49.76
Net Income Growth
------
Shares Outstanding (Basic)
938882584135
Shares Outstanding (Diluted)
938882584135
Shares Change
5.59%8.33%42.00%38.79%17.57%42.60%
EPS (Basic)
-4.51-1.28-3.36-1.96-1.42-1.41
EPS (Diluted)
-4.52-1.28-3.36-1.96-1.42-1.41
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-349.8-73.47-251.44-117.59-90.62-58.42
Free Cash Flow Per Share
-3.76-0.83-3.08-2.04-2.19-1.66
Gross Margin
--43.89%---75.80%-108.15%
Operating Margin
-1267.34%-72.84%-4671.07%-574.85%-122.72%-179.91%
Profit Margin
-1149.59%-51.99%-3921.10%-483.05%-115.17%-178.10%
Free Cash Flow Margin
-957.40%-33.59%-3592.01%-502.85%-177.92%-209.09%
EBITDA
-460.33-156.61-324.59-131.95-60.4-48.54
EBITDA Margin
--71.61%---118.59%-173.73%
D&A For EBITDA
2.712.72.392.482.11.73
EBIT
-463.04-159.31-326.98-134.43-62.5-50.27
EBIT Margin
--72.84%---122.72%-179.91%
Revenue as Reported
36.54218.71723.3950.9327.94
SEC Filings: 10-K · 10-Q